Abstract:Liver Kinase B1 (LKB1), encoded by Serine-Threonine Kinase 11 ( STK11 ), is a master kinase that regulates cell migration, polarity, proliferation, and metabolism through downstream adenosine monophosphate-activated protein kinase (AMPK) and AMPK-related kinase signalling. Since genetic screens identified STK11 mutations in Peutz-Jeghers Syndrome, STK11 mutants have been implicated in tumourigenesis labelling it as a tumour suppressor. In support of this, several compounds reduce tumour burden through upregulating LKB1 signalling, and LKB1-AMPK agonists are cytotoxic to tumour cells. However, in certain contexts, its role in cancer is paradoxical as LKB1 promotes tumour cell survival by mediating resistance against metabolic and oxidative stressors. LKB1 deficiency has also enhanced the selectivity and cytotoxicity of several cancer therapies. Taken together, there is a need to develop LKB1-specific pharmacological compounds, but prior to developing LKB1 inhibitors, further work is needed to understand LKB1 activity and regulation. However, investigating LKB1 activity is strenuous as cell/tissue type, mutations to the LKB1 signalling pathway, STE-20-related kinase adaptor protein (STRAD) binding, Mouse protein 25-STRAD binding, splicing variants, nucleocytoplasmic shuttling, post-translational modifications, and kinase conformation impact the functional status of LKB1. For these reasons, guidelines to standardize experimental strategies to study LKB1 activity, associate proteins, spliced isoforms, post-translational modifications, and regulation are of upmost importance to the development of LKB1-specific therapies. Therefore, to assess the therapeutic relevancy of LKB1 inhibitors, this review summarizes the importance of LKB1 in cell physiology, highlights contributors to LKB1 activation, and outlines the benefits and risks associated with targeting LKB1.

Molecular Characterization of Cytosolic Phospholipase A2-β*

A novel role for the Ste20 kinase SLK in adhesion signaling and cell migration

FAK/src-family dependent activation of the Ste20-like kinase SLK is required for microtubule-dependent focal adhesion turnover and cell migration

Targeting the SLIT/ROBO pathway in tumor progression: molecular mechanisms and therapeutic perspectives

The Skp2 Pathway: A Critical Target for Cancer Therapy

Structure, Regulation, and (Patho-)Physiological Functions of the Stress-Induced Protein Kinase CK1 Delta (CSNK1D).

Synthetic dysmobility screening reveals a phosphorylation-independent facet of the SLK-Ezrin-F-actin signaling cascade.

Cancer Cell-Type-Dependent Modifications of Metastatic Parameters by SLIT2-ROBO1 and RHOA cAMP Signaling in Response to TGFβ1 and FGF2

PKD1 Phosphorylation-Dependent Degradation of SNAIL by SCF-FBXO11 Regulates Epithelial-Mesenchymal Transition and Metastasis.

Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia.

Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases

Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development

The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells

Extensive Dysregulation of SLK Splicing in Cancers Impacts Metastasis

Focal adhesion kinase: from biological functions to therapeutic strategies

Multiple Functions of Mammalian Germinal Center Kinases

KLHL20 and its role in cell homeostasis: A new perspective and therapeutic potential

Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Lateral root bridging as a strategy to enhance L‐DOPA production in Stizolobium hassjoo hairy root cultures by using a mesh hindrance mist trickling bioreactor

LKB1 biology: assessing the therapeutic relevancy of LKB1 inhibitors

Krüppel-like factors in tumors: Key regulators and therapeutic avenues